Last 47 quarters of trend data · Healthcare · Medical Supplies & Consumables
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -6.02 | — | — | — | — | — | — | — | 19.46 | 49.44 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.44 | 0.31 | 0.51 | 0.45 | 0.68 | 0.45 | 0.51 | 0.68 | 1.14 | 0.55 | 0.54 | 0.61 | 0.60 | 1.40 | 0.42 | 0.15 | 0.19 | 0.15 | 0.68 | 0.63 | 0.88 |
| — | -32.2% | -0.4% | -34.1% | -40.3% | -17.0% | -5.1% | +10.9% | +88.8% | -60.9% | +27.1% | +305.8% | +223.9% | +818.7% | -38.3% | -75.9% | -78.9% | -89.2% | -61.0% | -47.5% | -29.9% | |
| P/B Ratio | 0.75 | 0.62 | 0.98 | 0.89 | 1.17 | 0.96 | 1.22 | 2.06 | 4.42 | 2.40 | 2.36 | 2.54 | 2.66 | 10.60 | 2.65 | 0.83 | 0.86 | 0.56 | — | 15.18 | 5.08 |
| — | -35.0% | -19.7% | -56.8% | -73.6% | -60.1% | -48.2% | -19.1% | +66.1% | -77.4% | -11.0% | +207.6% | +208.9% | +1779.8% | — | -94.6% | -83.0% | -88.0% | — | +615.4% | +178.0% | |
| P/FCF | 19.81 | 3.73 | — | 3.73 | — | 4.33 | — | 35.68 | 7.88 | 12.19 | — | — | — | — | — | — | — | — | — | — | — |
| — | -13.9% | — | -89.6% | — | -64.5% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | 58.49 | — | — | — | 676.50 | 13.17 | 13.84 | — | 4884.05 | — | — | — | — | — | — | — | — | — |
| — | — | — | -91.4% | — | — | — | -86.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | 16.60 | 25.61 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 16.9% | 18.2% | 16.7% | 21.1% | 14.3% | 15.6% | 16.1% | 14.7% | 22.0% | 17.6% | 13.5% | 13.0% | 9.3% | 5.7% | 13.2% | 12.1% | 4.2% | 9.3% | -4.9% | -14.6% | -2.1% |
| — | +17.1% | +3.9% | +43.6% | -35.3% | -11.6% | +19.0% | +13.3% | +137.9% | +208.3% | +2.3% | +7.2% | +122.8% | -38.8% | +371.1% | +183.3% | +302.0% | +639.6% | -288.1% | -673.1% | -190.9% | |
| Operating Margin | -6.8% | -6.0% | -8.5% | -2.2% | -9.9% | -8.4% | -7.2% | -2.1% | 6.8% | 2.0% | -5.8% | -2.5% | -7.3% | -16.4% | -7.3% | -10.2% | -19.8% | -24.0% | -41.1% | -54.5% | -43.6% |
| — | +28.9% | -18.7% | -3.1% | -245.5% | -521.0% | -23.1% | +15.0% | +193.6% | +112.2% | +19.5% | +75.7% | +63.2% | +31.8% | +82.3% | +81.3% | +54.5% | +53.6% | +11.5% | -2.4% | +0.4% | |
| Net Margin | -7.7% | -6.6% | -9.3% | -3.0% | -11.0% | -9.3% | -8.0% | -3.1% | 5.9% | 1.3% | -7.6% | -6.8% | -7.9% | -18.3% | -8.9% | -12.2% | -22.4% | -26.6% | -44.4% | -58.3% | -47.4% |
| — | +29.0% | -15.6% | +1.5% | -287.3% | -799.2% | -4.9% | +55.2% | +174.6% | +107.3% | +14.2% | +44.0% | +64.9% | +31.2% | +80.0% | +79.0% | +52.7% | +52.1% | +11.3% | -2.1% | +1.4% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -15.3% | -3.3% | -4.4% | -1.5% | -5.2% | -4.8% | -4.7% | -2.4% | 6.3% | 1.6% | -8.3% | -7.1% | -12.1% | -30.0% | -13.1% | -15.6% | -23.1% | -64.8% | — | -131.2% | -51.8% |
| — | +31.4% | +6.8% | +38.9% | -182.2% | -410.0% | +42.8% | +65.3% | +152.4% | +105.2% | +37.1% | +54.8% | +47.8% | +53.8% | — | +88.1% | +55.4% | -71.1% | — | -477.4% | -105.2% | |
| ROA | -9.1% | -2.1% | -2.8% | -1.0% | -3.2% | -2.8% | -2.7% | -1.3% | 3.0% | 0.7% | -3.4% | -2.9% | -4.1% | -8.4% | -4.0% | -4.7% | -7.4% | -10.3% | -16.7% | -16.7% | -12.4% |
| — | +26.5% | -4.6% | +25.7% | -205.4% | -523.4% | +20.4% | +54.9% | +173.2% | +107.9% | +16.3% | +38.4% | +44.2% | +18.2% | +75.9% | +71.9% | +40.3% | +18.5% | -58.1% | -56.8% | -21.2% | |
| ROIC | -10.2% | -2.0% | -2.8% | -0.8% | -3.5% | -3.1% | -3.2% | -1.3% | 5.1% | 1.4% | -3.7% | -1.5% | -5.8% | -13.2% | -5.7% | -6.4% | -14.4% | -27.6% | -34.0% | -35.4% | -34.4% |
| — | +35.5% | +13.0% | +37.4% | -168.1% | -318.6% | +12.7% | +16.0% | +188.5% | +110.8% | +35.6% | +76.6% | +60.0% | +52.3% | +83.2% | +81.8% | +58.1% | +30.2% | +18.2% | +47.6% | +26.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.34 | 0.40 | 0.40 | 0.34 | 0.35 | 0.46 | 0.41 | 0.42 | 0.49 | 0.61 | 0.69 | 0.63 | 0.69 | 1.68 | 1.23 | 1.16 | 1.38 | 1.19 | — | 11.40 | 2.67 |
| — | -13.8% | -1.7% | -18.8% | -27.1% | -24.7% | -40.6% | -34.2% | -29.6% | -63.7% | -44.2% | -45.6% | -49.9% | +41.9% | — | -89.8% | -48.3% | -21.0% | — | +1527.1% | +386.9% | |
| Debt / EBITDA | — | — | — | 84.27 | — | — | — | 563.96 | 5.72 | 13.51 | — | 4479.67 | — | — | — | — | — | — | — | — | — |
| — | — | — | -85.1% | — | — | — | -87.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 3.98 | 3.25 | 3.74 | 3.98 | 3.92 | 2.89 | 2.95 | 2.63 | 2.41 | 2.00 | 1.79 | 1.73 | 1.32 | 1.58 | 1.97 | 2.00 | 2.19 | 2.55 | 1.27 | 1.68 | 2.12 |
| — | +12.7% | +27.0% | +51.6% | +62.2% | +44.5% | +65.1% | +52.0% | +83.4% | +26.5% | -9.4% | -13.4% | -39.9% | -38.0% | +55.7% | +18.6% | +3.4% | +65.6% | -76.0% | -69.0% | -65.5% | |
| Quick Ratio | 3.63 | 3.00 | 3.43 | 3.63 | 3.50 | 2.51 | 2.50 | 2.22 | 2.00 | 1.60 | 1.38 | 1.38 | 1.06 | 1.25 | 1.60 | 1.67 | 1.93 | 2.27 | 0.98 | 1.49 | 1.93 |
| — | +19.7% | +37.5% | +63.5% | +75.2% | +56.4% | +81.1% | +61.1% | +88.5% | +28.6% | -13.7% | -17.4% | -45.1% | -45.1% | +62.6% | +12.0% | -0.1% | +61.9% | -80.0% | -70.9% | -66.8% | |
| Interest Coverage | -3.73 | -3.17 | -4.69 | -0.94 | -5.15 | -4.41 | -4.47 | -1.62 | 6.51 | 2.48 | -3.02 | -0.36 | -3.55 | -7.37 | -3.52 | -4.40 | -7.80 | -9.24 | -12.26 | -14.21 | -11.45 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying RMTI stock.
Rockwell Medical, Inc.'s current P/E is -6.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Rockwell Medical, Inc.'s current operating margin is -6.8%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Rockwell Medical, Inc.'s business trajectory between earnings reports.